Contact
Please use this form to send email to PR contact of this press release:
Maxwell Biomedical Completes First-in-Human Study Enrollment and Testing of Spatial Resynchronization™ Therapy
TO:
Randy Werneth
Maxwell Biomedical
+1 858-877-3070